Healthcare & Life Sciences
Angiex
United Statesangiex.com
Angiex is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Angiex
Angiex is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Angiex develops Nuclear-Delivered Antibody-Drug Conjugates (ND-ADCs) to deliver chemotherapeutic agents directly to the nuclei of tumor and tumor blood vessel cells for the treatment of solid tumors.
Explore Angiex's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.